Our Solutions

EU AI Act Readiness Assessment

A structured diagnostic that shows where you stand against the EU AI Act—and delivers a prioritised roadmap to full compliance and EU market access.

The EU Artificial Intelligence Act (Regulation (EU) 2024/1689) imposes significant obligations on providers of high-risk AI systems and general-purpose AI (GPAI) models. For organisations established outside the EU, those obligations include risk classification, technical documentation, quality management, and—where required—appointment of an EU Authorised Representative before placing systems or models on the Union market.

The DPS EU AI Act Readiness Assessment is a powerful diagnostic solution designed to evaluate your compliance status quickly and accurately. It replaces guesswork with a clear picture of gaps, risks, and next steps—so leadership, legal, and product teams can plan with confidence.

Why a readiness assessment matters

Many non-EU providers underestimate how early AI Act obligations bite. Classification decisions, documentation quality, QMS maturity, and Authorised Representative appointment all interact. Waiting until product launch often creates last-minute blockers, regulatory exposure, and delayed EU go-to-market.

Who it is for

Non-EU AI providers

Companies outside the European Union placing high-risk AI systems or GPAI models on the EU market, or preparing to do so.

Product & compliance leaders

Teams that need an independent, structured view of readiness before appointing an Authorised Representative or scaling into the EU.

Investors & partners

Stakeholders seeking assurance that EU AI Act exposure is understood and managed before commercial commitments.

Organisations mid-journey

Providers that have started documentation or QMS work but need prioritisation, validation, and a clear path to completion.

What we assess

The readiness assessment covers the areas that most often determine whether a non-EU provider can enter and remain on the EU market lawfully and sustainably:

1

Role & scope

Provider vs deployer/importer distinctions; which AI systems or models fall in scope; territorial application to the EU market.

2

Risk classification

High-risk (Annex III and related criteria), GPAI and systemic-risk considerations, prohibited practices, and edge cases that often cause misclassification.

3

Technical documentation & conformity

Readiness of technical documentation, EU declaration of conformity pathways, and evidence needed for authority requests.

4

Risk management & impact assessment

Article 9 risk management maturity and alignment with impact assessment expectations (including support from DPS AI Impact Assessment tools).

5

Quality Management System (Article 17)

Whether your QMS is designed for high-risk AI obligations, auditability, and ongoing control—or needs a structured build-out.

6

Authorised Representative readiness

Whether AR appointment is mandatory, mandate scope, documentation the AR must hold, and operational readiness to cooperate with EU authorities.

7

Post-market & governance

Monitoring, logging, human oversight, registration/database expectations, and internal ownership for ongoing compliance.

How the assessment works

  1. Intake & scoping — We capture your AI portfolio, business model, target EU use cases, and current compliance artefacts.
  2. Structured diagnostic — Using the DPS readiness platform and expert review, we evaluate status against core AI Act requirements relevant to your profile.
  3. Gap analysis — Findings are scored and grouped by severity, legal criticality, and implementation effort.
  4. Prioritised roadmap — You receive a clear sequence of actions: what must be fixed before market placement, what can follow, and who owns each item.
  5. Path to execution — Optional next steps with DPS: Authorised Representative mandate, QMS (Article 17), and AI Impact Assessment support on our integrated platform.

What you receive

Technology-enabled by DPS

The readiness assessment is not a one-off spreadsheet exercise. It is delivered through DPS’s purpose-built compliance platform—the same ecosystem that supports our Authorised Representative clients with:

Learn more about the broader DPS offering on The DPS Advantage.

Frequently asked questions

Is the assessment a substitute for legal advice?

It is a structured compliance diagnostic and roadmap. It does not replace formal legal opinions for your specific facts, but it gives a practical, regulation-aligned foundation for decisions and counsel engagement.

How long does it take?

Timing depends on portfolio complexity and document availability. Many organisations complete the core diagnostic and roadmap within a focused engagement once key system information is provided.

Can this lead into AR appointment?

Yes. Where Articles 22 or 54 require an Authorised Representative, the assessment clarifies mandate readiness and provides a clean handoff into DPS AR services.

Do we need to be high-risk to benefit?

No. Classification uncertainty is itself a reason to assess. Confirming you are out of high-risk or GPAI scope—or that exemptions apply—can be as valuable as building a full compliance plan.

Ready to know where you stand?

Request a free initial discussion. We will outline how the EU AI Act Readiness Assessment applies to your AI systems and what a prioritised roadmap would look like for your organisation.

Get in Touch